Next Generation Sequencing Market is anticipated to reach USD 21.4 billion by 2025. NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer. NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule. Advancement of NGS has helped biological and medical discovery and research. It has helped in various applied fields which includes biotechnology, forensic research, virology and medical diagnosis. NGS has made possible sequencing of DNA of various species including the human genome.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market/request-sample
Market Synopsis of Next Generation Sequencing Market:
Introduction of advanced genetic
sequencing and development of advance techniques for whole genomes are the
major drivers contributing to the overall market growth. Increasing incidences
of cancer and infectious diseases coupled with aging population is expected to
fuel the demand for these technologies. Further, the overall cost of genome
sequencing is expected to reduce drastically on account of rapid development
through research and innovation. High capacity genome sequencing has been
contributing significantly towards the market growth.
NGS has wide applications in the
field of exome and genome sequencing. They are widely used in the treatment of
infectious disease and cancer. NGS has shown a key presence in pathogen
analysis which has been helpful in the treatment of infectious diseases. The
need for effective diagnosis for cancer and high growing usage of combinational
biomarkers are other factors contributing to the growth of the market in recent
years.
NGS has been mostly a topic of
research and development in the previous decade. At present they find
applications in the field of oncology, prenatal testing, HLA testing,
idiopathic diseases, and medical research. Research and development in the
field of HLA and prenatal testing have provided new avenues to doctors in
gaining insights during organ matching and organ rejection.
The development in the treatment
of genetic anomalies and diseases with the help of prenatal genome sequencing
has been driving the NGS market. This technology has also helped the
pharmaceutical companies in developing essential drugs for the treatment of
cancer and infectious diseases. Growing concerns and increasing incidences of
cancer is expected to be the major driving factor for the development of NGS.
NGS in the field of organ
transplant provides great opportunities over the forecast period. It is
important that the characteristics of both the donors and the acceptors match
for a successful transplant. NGS helps in studying the immune response to the
transplanted organ. Medical tourism development in countries including the U.S,
Israel, Singapore and Australia provide bright prospects for overall growth of
the market.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market
Table of Contents:-
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Next Generation
Sequencing: Market Variables, Trends & Scope
Chapter 4 Next Generation
Sequencing: Product Estimates & Trend Analysis
Chapter 5 Next Generation
Sequencing: Application Estimates & Trend Analysis
Chapter 6 Next Generation
Sequencing: End-use Estimates & Trend Analysis
Chapter 7 Next Generation
Sequencing: Industrial End-use Estimates & Trend Analysis
Chapter 8 Next Generation
Sequencing: Regional Estimates & Trend Analysis
Chapter 9 Competitive Landscape
Chapter 10 Next Generation
Sequencing: Manufacturers Company Profiles
Get in touch
At Million Insights, we work with
the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
No comments:
Post a Comment